Compounds > lamivudine
Page last updated: 2024-08-24

lamivudine and bay 41-4109

lamivudine has been researched along with bay 41-4109 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Li, S; Wang, L; Xia, G; Xu, X; Yang, X; Zhao, G; Zheng, Z; Zhou, X; Zhu, X1
Wang, G; Zhang, F1
Goldmann, S; Li, J; Liu, X; Luo, Z; Ren, Q; Wang, C; Zhang, J; Zhang, Y1
Dong, Y; Jiang, C; Li, S; Liu, G; Ma, Y; Pei, Y; Tan, X; Wang, C; Wang, L; Xiang, Y1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Arzumanyan, A; Clayton, MM; Feitelson, MA; Goldmann, S; Li, J; Liu, B; Ren, Q; Schinazi, RF; Wang, Z; Wu, G; Zhang, F; Zhang, Y1

Reviews

1 review(s) available for lamivudine and bay 41-4109

ArticleYear
A review of non-nucleoside anti-hepatitis B virus agents.
    European journal of medicinal chemistry, 2014, Mar-21, Volume: 75

    Topics: Animals; Antiviral Agents; Biological Products; Hepatitis B; Hepatitis B virus; Humans; Small Molecule Libraries

2014

Other Studies

5 other study(ies) available for lamivudine and bay 41-4109

ArticleYear
2,4-Diaryl-4,6,7,8-tetrahydroquinazolin-5(1H)-one derivatives as anti-HBV agents targeting at capsid assembly.
    Bioorganic & medicinal chemistry letters, 2010, Jan-01, Volume: 20, Issue:1

    Topics: Antiviral Agents; Capsid; Quinazolinones; Structure-Activity Relationship; Virus Replication

2010
Discovery of hepatitis B virus capsid assembly inhibitors leading to a heteroaryldihydropyrimidine based clinical candidate (GLS4).
    Bioorganic & medicinal chemistry, 2017, 02-01, Volume: 25, Issue:3

    Topics: Administration, Oral; Animals; Antiviral Agents; Capsid; Crystallography, X-Ray; Dogs; Dose-Response Relationship, Drug; Drug Discovery; Drug Resistance, Viral; Hep G2 Cells; Hepatitis B virus; Humans; Models, Molecular; Molecular Structure; Pyrimidines; Structure-Activity Relationship; Thiazoles

2017
Discovery of (1
    Journal of medicinal chemistry, 2020, 06-11, Volume: 63, Issue:11

    Topics: Animals; Antiviral Agents; Binding Sites; Capsid; Capsid Proteins; Cell Line; DNA, Viral; Drug Design; Drug Resistance, Viral; Hepatitis B virus; Humans; Mice; Microsomes, Liver; Protein Structure, Tertiary; Pyrazoles; Pyridines; Solubility; Structure-Activity Relationship; Sulfonamides; Virus Assembly; Virus Replication

2020
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Preclinical characterization of GLS4, an inhibitor of hepatitis B virus core particle assembly.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:11

    Topics: Animals; Antiviral Agents; Cell Line; DNA, Viral; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Humans; Lamivudine; Male; Mice; Mice, Nude; Microbial Sensitivity Tests; Primary Cell Culture; Pyridines; Pyrimidines; Thiazoles; Viral Core Proteins; Viremia; Virion; Virus Replication

2013